Form 4: AVITA Medical Director Robert McNamara Acquires 11,000 Shares
SEC Form 4 Filing
Director Robert McNamara of AVITA Medical, Inc. [RCEL] purchased 11,000 shares of common stock at $8.30 per share on March 6, 2025.
Summary
- On March 6, 2025, Robert McNamara, a director of AVITA Medical, Inc. (RCEL), acquired 11,000 shares of common stock.
- The purchase price was $8.30 per share.
- Following the transaction, McNamara directly owns 56,749 shares of AVITA Medical, Inc.
- This includes unvested Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of a director's stock purchase. The size of the purchase is not significant enough to indicate strong positive or negative sentiment.
Industry Context
This is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored by regulators to prevent illegal insider trading.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock purchase transaction |
| 03/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.